MedPath

A Randomized Controlled Trial for Hypertension Control by Integrating Cloud BP System and CPOE

Not Applicable
Completed
Conditions
Hypertension
Interventions
Device: Cloud-based home BP monitoring
Registration Number
NCT02175511
Lead Sponsor
Taipei Medical University
Brief Summary

Importance: Less than fifty percent of patients with hypertensive disease manage to maintain their blood pressure (BP) within normal levels. Practical (Pragmatic) and sustainable models are needed in order to improve BP management in patients with hypertension.

Objective: To evaluate whether cloud BP system integrated with computerized physician order entry (CPOE) is useful for improving BP management as compared with traditional care.

Detailed Description

Design, Setting and Patients: A randomized clinical trial study of 382 adults recruited from 786 patients who had been diagnosed with hypertension and receiving treatment for hypertension in two district hospitals in the north of Taiwan. Physicians had access to cloud-based BP data from CPOE. Neither participants nor investigators were blinded to group assignment. The study was conducted for a period of seven months.

Interventions: Patients from two hospitals were randomized into a control group which received traditional care (n=212) and an intervention group (n=170) which received a cloud-based home BP monitoring device. The device measured and transmitted BP data to the cloud server, which was integrated with the CPOE system in the hospitals. Physicians could access the BP data during the patient encounter to adjust the antihypertensive therapy accordingly. Meanwhile, patients could browse their own BP data from their computers, smart phones, tablets and so on.

Primary Outcome(s) and Measure(s): The primary outcomes were control of systolic BP to less than 140 mm Hg and diastolic BP to less than 90 mm Hg at two, four and six months. The secondary outcomes were changes in BP and antihypertensive drug prescription at two, four and six months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
382
Inclusion Criteria
  • Secondary hypertension
  • Expectant mother
  • Stroke, myocardial infarction or had surgery within 3 months
  • Atrial fibrillation
  • Inter-arm difference (IAD) >20 mm Hg
  • Unsuitability as recognized by physicians.
Exclusion Criteria
  • Unable to participate in this trial for the whole process
  • Lived alone and unable to read Text Message

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cloud-based home BP monitoringCloud-based home BP monitoring170 were assigned to the experimental group
Primary Outcome Measures
NameTimeMethod
The proportion of patients with controlled BP (<140/90 mm Hg)Patients who participated in this trial will be followed for an expected average of 6 months
Secondary Outcome Measures
NameTimeMethod
The changes in BP and antihypertensive drug prescriptionPatients who participated in this trial will be followed for an expected average of 6 months
© Copyright 2025. All Rights Reserved by MedPath